China SXT Pharmaceuticals Inc (NASDAQ: SXTC) has a higher price-to-earnings ratio of 0.22x compared to its average ratio. SXTC has 36-month beta value of 1.18.
The public float for SXTC is 3.43M, and currently, short sellers hold a 5.71% ratio of that float. The average trading volume of SXTC on November 05, 2024 was 615.68K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SXTC) stock’s latest price update
China SXT Pharmaceuticals Inc (NASDAQ: SXTC)’s stock price has dropped by -9.64 in relation to previous closing price of 0.53. Nevertheless, the company has seen a loss of -18.83% in its stock price over the last five trading days. globenewswire.com reported 2024-10-07 that Jiangsu, China, Oct. 07, 2024 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (“SXTC” or the “Company”), (NASDAQ: SXTC) announced today that on October 3, 2024, the Company received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the Company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).
SXTC’s Market Performance
China SXT Pharmaceuticals Inc (SXTC) has experienced a -18.83% fall in stock performance for the past week, with a -33.39% drop in the past month, and a -50.71% drop in the past quarter. The volatility ratio for the week is 11.96%, and the volatility levels for the past 30 days are at 11.46% for SXTC. The simple moving average for the last 20 days is -19.60% for SXTC’s stock, with a simple moving average of -59.88% for the last 200 days.
SXTC Trading at -24.82% from the 50-Day Moving Average
After a stumble in the market that brought SXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.51% of loss for the given period.
Volatility was left at 11.46%, however, over the last 30 days, the volatility rate increased by 11.96%, as shares sank -33.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -43.66% lower at present.
During the last 5 trading sessions, SXTC fell by -18.83%, which changed the moving average for the period of 200-days by -71.83% in comparison to the 20-day moving average, which settled at $0.5957. In addition, China SXT Pharmaceuticals Inc saw -87.94% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SXTC
Current profitability levels for the company are sitting at:
- -3.0 for the present operating margin
- 0.25 for the gross margin
The net margin for China SXT Pharmaceuticals Inc stands at -3.31. The total capital return value is set at -0.51. Equity return is now at value -21.65, with -11.76 for asset returns.
Based on China SXT Pharmaceuticals Inc (SXTC), the company’s capital structure generated 0.16 points at debt to capital in total, while cash flow to debt ratio is standing at -0.73.
Currently, EBITDA for the company is -1.89 million with net debt to EBITDA at 1.45. When we switch over and look at the enterprise to sales, we see a ratio of -3.23. The receivables turnover for the company is 1.78for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.60.
Conclusion
To put it simply, China SXT Pharmaceuticals Inc (SXTC) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
